Insurer Stocks Soar After CMS Finalizes 2027 Medicare Payments
CMS boosts 2027 Medicare payments 2.5%, giving insurers $13B+, keeping plans stable and seniors’ benefits solid. Stocks jump.
/ 7 items
#CVS↓
CVS Health Misses 2026 Profit Forecast, Shares Drop
CVS Health falls short of Wall Street's 2026 profit expectations despite beating Q4 estimates. Stock drops 3% as company maintains cautious outlook amid healthcare industry challenges.
Trump Administration Proposes Near-Flat Medicare Advantage Rates, Disappointing Insurers
Trump's CMS proposes minimal 0.09% Medicare payment increase for 2027, far below Wall Street's 4-6% expectations, while eliminating controversial billing practices.
Amazon Pharmacy Now Offers Wegovy Weight-Loss Pill with Affordable Options
Amazon Pharmacy now sells Wegovy weight-loss pill. Insured pay $25/month, uninsured start at $149. Needle-free option available nationwide.
Novo Nordisk Launches Wegovy Weight-Loss Pill in the U.S.
Novo Nordisk's once-daily Wegovy pill launches in the U.S. at $149/month for self-paying customers, intensifying competition with Eli Lilly in the weight-loss drug market.
CVS Health Boosts 2025 Outlook, Forecasts Strong 2026 Growth
CVS Health raises 2025 revenue guidance to $400B and projects adjusted earnings of $7.00-$7.20 per share for 2026, signaling turnaround momentum under CEO David Joyner.